Dr Mark Trozzi（マーク・トロッツィ博士）がCOVID-19 mRNAワクチンによる障害報告に関する査読済み論文の約1,000件を掲載したサイトを作っています。
1000 peer reviewed articles on “Vaccine” injuries
その中で4番目に多くの件数が報告されている「脳静脈血栓症（cerebral venous thrombosis; CVT）」の論文リストを転載させていただきます。
脳静脈血栓症（cerebral venous thrombosis; CVT）は脳静脈が閉塞に伴い脳出血や静脈性梗塞を発症する脳血管障害の一病型である。脳の静脈経路に血栓が生じ、血栓に対応する領域に脳梗塞が生じる脳卒中の一種。
総論文数: 61
Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19:
https://www.sciencedirect.com/science/article/pii/S0735109721051949
Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin basedanticoagulation:
https://www.sciencedirect.com/science/article/pii/S1871402121002046
Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine:
https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098
Cerebral venous sinus thrombosis after vaccination: the United Kingdomexperience:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext
US case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020:
https://pubmed.ncbi.nlm.nih.gov/33929487/
Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET):
https://pubmed.ncbi.nlm.nih.gov/33871350/
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematicreview:
https://www.sciencedirect.com/science/article/pii/S0022510X21003014
Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination withCOV2.S:
https://www.sciencedirect.com/science/article/pii/S0196064421003425
A rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19vaccination:
https://www.sciencedirect.com/science/article/pii/S0735675721005714
Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of twocases in the Unitet Kingdom:
https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X
Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination:
https://www.sciencedirect.com/science/article/pii/S0213485321000839
COVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase:
https://pubmed.ncbi.nlm.nih.gov/33863748/
Cerebral venous thrombosis associated with the covid-19 vaccine in Germany:
https://onlinelibrary.wiley.com/doi/10.1002/ana.26172
Cerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event:
https://pubmed.ncbi.nlm.nih.gov/34133027/
The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34001390/
Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in an elderly, non-comorbid Indian male treated with conventional heparin-warfarin-basedanticoagulation:
https://www.sciencedirect.com/science/article/pii/S1871402121002046
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after covid-19 vaccination; a systematic review:
https://pubmed.ncbi.nlm.nih.gov/34365148/
A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccine:
https://pubmed.ncbi.nlm.nih.gov/33917902/
Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34247246/
Cerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford-AstraZeneca COVID-19: a missed opportunity for a rapid return on experience:
https://pubmed.ncbi.nlm.nih.gov/34033927/
Diagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia:
https://pubmed.ncbi.nlm.nih.gov/33914590/
Venous sinus thrombosis after vaccination with ChAdOx1 nCov-19:
https://pubmed.ncbi.nlm.nih.gov/34420802/
Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency:
https://pubmed.ncbi.nlm.nih.gov/34293217/
Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study:
https://pubmed.ncbi.nlm.nih.gov/33952445/
Cerebral venous thrombosis associated with COVID-19 vaccine in Germany:
https://pubmed.ncbi.nlm.nih.gov/34288044/
Malignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia:
https://pubmed.ncbi.nlm.nih.gov/34341358/
Cerebral venous sinus thrombosis associated with thrombocytopenia after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/33845870/
central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental:
https://pubmed.ncbi.nlm.nih.gov/34478433/
Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation:
https://pubmed.ncbi.nlm.nih.gov/34186376/
Cerebral venous sinus thrombosis 2 weeks after? rst dose of SARS-CoV-2 mRNA vaccine:
https://pubmed.ncbi.nlm.nih.gov/34101024/
Deep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV-2 mRNA vaccine:
https://pubmed.ncbi.nlm.nih.gov/33687691/
Vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high mortality rate: a case series:
https://pubmed.ncbi.nlm.nih.gov/34393988/
Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis:
https://pubmed.ncbi.nlm.nih.gov/34129181/
Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34247246/
Cerebral venous thrombosis following COVID-19 vaccination
https://pubmed.ncbi.nlm.nih.gov/34045111/
Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, centered on cerebral venous sinus thrombosis (CVST):
https://pubmed.ncbi.nlm.nih.gov/34092166/
Cerebral venous thrombosis associated with COVID-19 vaccine in Germany:
https://pubmed.ncbi.nlm.nih.gov/34288044/
Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management:
https://pubmed.ncbi.nlm.nih.gov/34327553/
Cerebral venous thrombosis and thrombocytopenia after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/33878469/
Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom:
https://pubmed.ncbi.nlm.nih.gov/33857630/
Cerebral venous thrombosis induced by SARS-CoV-2 vaccine:
https://pubmed.ncbi.nlm.nih.gov/34090750/
Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34333995/
Cerebral venous thrombosis after the BNT162b2 mRNA SARS-CoV-2 vaccine:
https://pubmed.ncbi.nlm.nih.gov/34111775/
Cerebral venous thrombosis after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34045111/
Lethal cerebral venous sinus thrombosis after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/33983464/
Cerebral venous sinus thrombosis in the U.S. population, After SARS-CoV-2 vaccination with adenovirus and after COVID-19:
https://pubmed.ncbi.nlm.nih.gov/34116145/
Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular administration of the vaccine:
https://pubmed.ncbi.nlm.nih.gov/34286453/
Central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental:
https://pubmed.ncbi.nlm.nih.gov/34478433/
Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading? rst brain MRI: https://pubmed.ncbi.nlm.nih.gov/34244448/
Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S:
https://pubmed.ncbi.nlm.nih.gov/34226070/
Cerebral venous sinus thrombosis associated with post-vaccination thrombocytopenia by COVID-19: https://pubmed.ncbi.nlm.nih.gov/33845870/
Cerebral venous sinus thrombosis 2 weeks after the? rst dose of SARS-CoV-2 mRNA vaccine:
https://pubmed.ncbi.nlm.nih.gov/34101024/
Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST):
https://pubmed.ncbi.nlm.nih.gov/34092166/
Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency:
https://pubmed.ncbi.nlm.nih.gov/34293217/
A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination:
https://pubmed.ncbi.nlm.nih.gov/34274191/
Massive cerebral venous thrombosis and venous basin infarction as late complications of COVID-19: a case report:
https://pubmed.ncbi.nlm.nih.gov/34373991/
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia:
https://pubmed.ncbi.nlm.nih.gov/34261296/
Cerebral venous thrombosis developing after vaccination. COVID-19: VITT, VATT, TTS and more:
https://pubmed.ncbi.nlm.nih.gov/34695859/
Cerebral venous thrombosis and myeloproliferative neoplasms: a three-center study of 74 consecutive cases:
https://pubmed.ncbi.nlm.nih.gov/34453762/
Vaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford-AstraZeneca COVID-19: a missed opportunity for rapid return on experience:
https://www.sciencedirect.com/science/article/pii/S235255682100093X
Case report: Take a second look: Cerebral venous thrombosis related to Covid-19 vaccination andthrombotic thrombocytopenia syndrome:
https://pubmed.ncbi.nlm.nih.gov/34880826/
